Investor Relations

SEC Filings

Form 10-Q
VANDA PHARMACEUTICALS INC. filed this Form 10-Q on 08/02/2018
Document Outline
Entire Document (3410.5 KB)
Subdocument 1 - 10-Q - 10-Q
Page 1 - UNITED STATES
Page 2 - Vanda Pharmaceuticals Inc.
Page 3 - CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Page 4 - Part I FINANCIAL INFORMATION
Page 5 - VANDA PHARMACEUTICALS INC.
Page 6 - VANDA PHARMACEUTICALS INC.
Page 7 - VANDA PHARMACEUTICALS INC.
Page 8 - VANDA PHARMACEUTICALS INC.
Page 9 - VANDA PHARMACEUTICALS INC.
Page 10 - Revenue Recognition
Page 11 - Chargebacks:
Page 12 - Financial Instruments Credit Losses,
Page 13 - 3. Marketable Securities
Page 14 - 5. Inventory
Page 15 - Fanapt
Page 16 - 8. Commitments and Contingencies
Page 17 - Fanapt.
Page 18 - Purchase commitments
Page 19 - Restricted Stock Units
Page 20 - Stock-Based Compensation
Page 21 - 13. Earnings per Share
Page 22 - Approved Drug Products with Therapeutic Equivalence Evaluations
Page 23 - Overview
Page 24 - Risk Factors
Page 25 - Prompt-pay:
Page 26 - Research and development expenses
Page 27 - Recent Accounting Pronouncements
Page 28 - Selling, general and administrative expenses.
Page 29 - Cost of goods sold.
Page 30 - Intangible asset amortization
Page 31 - Cash Flow
Page 32 - Interest rate risks
Page 33 - Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures
Page 34 - Approved Drug Products with Therapeutic Equivalence Evaluations
Page 35 - N/A
Page 36 - N/A
Page 37 - SIGNATURES
Subdocument 2 - EX-31.1 - EX-31.1
Page 1 - N/A
Subdocument 3 - EX-31.2 - EX-31.2
Page 1 - N/A
Subdocument 4 - EX-32.1 - EX-32.1
Page 1 - N/A
Subdocument - EX-101.INS - XBRL INSTANCE DOCUMENT
Subdocument - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
Subdocument - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
Subdocument - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
Subdocument - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
Subdocument - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
Subdocument - XBRL Viewer
  
Home | About Vanda | Product Pipeline| Partnering | Investor Relations | News | Careers | Contact Us
Copyright © 2005-2019 Vanda Pharmaceuticals | Terms & Conditions | Privacy Policy